Witek, MaĆgorzata A.
Aufforth, Rachel D.
Wang, Hong
Kamande, Joyce W.
Jackson, Joshua M.
Pullagurla, Swathi R.
Hupert, Mateusz L.
Usary, Jerry
Wysham, Weiya Z.
Hilliard, Dawud
Montgomery, Stephanie
Bae-Jump, Victoria
Carey, Lisa A.
Gehrig, Paola A.
Milowsky, Matthew I.
Perou, Charles M.
Soper, John T.
Whang, Young E.
Yeh, Jen Jen
Martin, George
Soper, Steven A.
Article History
Received: 6 February 2017
Revised: 15 June 2017
Accepted: 28 June 2017
First Online: 25 July 2017
Competing interests
: The presented CTC isolation technology is being commercialized by Biofluidica, Inc. S.A.S. and M.L.H. hold equity shares in BioFluidica, Inc. M.A.W. declares conflict of interest as spouse of M.L.H. The remaining authors declare that they have no competing financial interests.